Tenet Healthcare Corporation $THC Position Reduced by Nordea Investment Management AB

Nordea Investment Management AB lowered its stake in Tenet Healthcare Corporation (NYSE:THC) by 7.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 66,795 shares of the company’s stock after selling 5,204 shares during the period. Nordea Investment Management AB owned 0.08% of Tenet Healthcare worth $13,332,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Norges Bank acquired a new stake in Tenet Healthcare during the second quarter valued at approximately $206,981,000. Eminence Capital LP acquired a new position in shares of Tenet Healthcare in the 3rd quarter worth approximately $225,263,000. Boston Partners increased its holdings in shares of Tenet Healthcare by 95.0% in the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after acquiring an additional 1,104,500 shares during the last quarter. AQR Capital Management LLC lifted its stake in Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after purchasing an additional 720,160 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in Tenet Healthcare by 375.7% in the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after purchasing an additional 624,125 shares during the period. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Thomas W. Arnst sold 8,000 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $238.85, for a total value of $1,910,800.00. Following the completion of the transaction, the executive vice president directly owned 12 shares of the company’s stock, valued at approximately $2,866.20. The trade was a 99.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 46,517 shares of company stock valued at $10,943,111 in the last quarter. Corporate insiders own 0.81% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Royal Bank Of Canada increased their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a report on Thursday, February 12th. KeyCorp boosted their price objective on shares of Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research report on Thursday, February 12th. Barclays raised their target price on shares of Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Jefferies Financial Group upped their target price on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Finally, TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $250.56.

Tenet Healthcare Trading Down 1.8%

Shares of NYSE:THC opened at $199.74 on Wednesday. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The company’s 50-day moving average price is $213.92 and its 200 day moving average price is $205.23. The company has a market cap of $17.37 billion, a PE ratio of 12.89, a P/E/G ratio of 0.98 and a beta of 1.39. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $247.21.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. Tenet Healthcare’s revenue was up 8.9% compared to the same quarter last year. During the same quarter last year, the business earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.